Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
252
days
Proteomic profiling of cisplatin-resistant and cisplatin-sensitive germ cell tumour cell lines using quantitative mass spectrometry
AuthorsA. Fichtner; H. Bohnenberger; O. Elakad; A. Richter; C. Lenz; C. Oing; P. Ströbel; S. Kueffer; D. Nettersheim; F. Bremmer
Affiliations1. Institute of Pathology, University Medical Center, Göttingen, Germany; 2. Department of Clinical Chemistry, University Medical Center, Göttingen, Germany; 3. Bioanalytical Mass Spectrometry Group, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany; 4. Department of Oncology, Hematology and Bone Marrow Transplantation with Division of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 5. Mildred Scheel Cancer Career Center HaTriCS4, University Medical Center Eppendorf, Hamburg, Germany; 6. Department of Urology, Urological Research Laboratory, Translational UroOncology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
104
days
Active surveillance for intermediate-risk prostate cancer
AuthorsMadhur Nayan; Filipe L. F. Carvalho; Adam S. Feldman
Affiliations1. Department of Urology, Massachusetts General Hospital, Boston, USA
62
days
Use of high-resolution micro-ultrasound to predict extraprostatic extension of prostate cancer prior to surgery: a prospective single-institutional study
AuthorsVittorio Fasulo; Nicolò Maria Buffi; Federica Regis; Marco Paciotti; Fancesco Persico; Davide Maffei; Alessandro Uleri; Alberto Saita; Paolo Casale; Rodolfo Hurle; Massimo Lazzeri; Giorgio Guazzoni; Giovanni Lughezzani
Affiliations1. Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; 2. Department of Urology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
169
days
Peritoneal carcinosis in male germ cell tumor patients: a registry study compiled by the German Testicular Cancer Study Group (GTCSG)
AuthorsChristoph Seidel; Marcus Hentrich; Stefanie Zschäbitz; Pia Paffenholz; Axel Heidenreich; Tim Nestler; Ben Tran; Stefanie Fischer; Gedske Daugaard; Sebastian Ochsenreither; Margarida Brito; Friedemann Zengerling; Constantin Schwab; Carsten Bokemeyer; Christoph Oing
Affiliations1. Department of Oncology, Hematology and Bone Marrow Transplantation with Division of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 2. Department of Medicine III-Haematology/Oncology, Red Cross Hospital, Munich, Germany; 3. Department of Medical Oncology, National Centre for Tumour Diseases, Heidelberg University Hospital, Heidelberg, Germany; 4. Department of Urology, University Hospital Cologne, Cologne, Germany; 5. Department of Urology, Federal Armed Services Hospital Koblenz, Koblenz, Germany; 6. Peter MacCallum Cancer Centre, Melbourne, Australia; 7. Department of Medical Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland; 8. Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; 9. Department of Medical Oncology and Hematology, Charité Campus Benjamin Franklin, Berlin, Germany; 10. Charité Comprehensive Cancer Center, Berlin, Germany; 11. Instituto Português de Oncologia de Lisboa, Lisboa, Portugal; 12. Department of Urology, University Hospital Ulm, Ulm, Germany; 13. Department of Pathology, National Centre for Tumour Diseases, Heidelberg University Hospital, Heidelberg, Germany; 14. Mildred Scheel Cancer Career Center HaTriCs4, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
63
days
Robotic RPLND for stage IIA/B nonseminoma: the Princess Margaret Experience
AuthorsG. J. Nason; Robert J. Hamilton
Affiliations1. Division of Urology, Department of Surgery, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada
98
days
The utility of prostate MRI within active surveillance: description of the evidence
AuthorsGeorgina Dominique; Wayne G. Brisbane; Robert E. Reiter
Affiliations1. Charles R. Drew University/David Geffen School of Medicine at UCLA Medical Education Program, Los Angeles, USA; 2. Institute of Urologic Oncology, Department of Urology, UCLA Medical Center, University of California Los Angeles, Los Angeles, USA; 3. Jonsson Comprehensive Cancer Center, University of California, Los Angeles, USA
185
days
Clinical characteristics, treatment patterns and relapse in patients with clinical stage IS testicular cancer
AuthorsMaximilian Peter Brandt; C. Ruf; K. P. Dieckmann; I. Syring; C. Ruckes; T. Nestler; H. U. Schmelz; R. Dotzauer; A. Hiester; P. Albers; D. Nettersheim; C. Bolenz; S. H. Loosen; A. Heidenreich; D. Pfister; A. Haferkamp; F. Zengerling; P. Paffenholz
Affiliations1. Department of Urology and Pediatric Urology, University Medical Center Mainz, University of Mainz, Mainz, Germany; 2. Department of Urology, Ulm, Germany; 3. Department of Urology, Asklepios Klinik Altona, Hamburg, Germany; 4. Klinik Und Poliklinik Für Urologie Und Kinderurologie, Universitätsklinikum Bonn, Bonn, Germany; 5. Interdisciplinary Center for Clinical Trials (IZKS), Mainz, Germany; 6. Department of Urology, Federal Armed Service Hospital Koblenz, Koblenz, Germany; 7. Department of Urology, Düsseldorf University Hospital, Düsseldorf, Germany; 8. Department of Urology, Urological Research Lab, Translational UroOncology, University Hospital Düsseldorf, Düsseldorf, Germany; 9. Department of Urology, Ulm University Hospital, Ulm, Germany; 10. Clinic for Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Düsseldorf, Germany; 11. Department of Urology, Urologic Oncology, Robot-Assisted and Specialized Urologic Surgery, University Hospital Cologne, Cologne, Germany
92
days
Impact of COVID-19 crisis on medical care of patients with metastasized uro-oncologic disease under systemic cancer therapy: a multicenter study in German university hospitals
AuthorsJulian P. Struck; Maike Schnoor; Andrea Schulze; Marie C. Hupe; Tomasz Ozimek; Immanuel A. Oppolzer; Marco J. Schnabel; Maximilian Burger; Christopher Darr; Viktor Gruenwald; Boris Hadaschik; Maximilian Weinke; Hubert Kuebler; Jonas C. Klockenbusch; Markus T. Grabbert; Christian Gratzke; Mario W. Kramer; Alexander Katalinic; Axel S. Merseburger
Affiliations1. Department of Urology, University Hospital Schleswig-Holstein, Luebeck, Germany; 2. Department of Social Medicine and Epidemiology and Department of Cancer Epidemiology, University of Luebeck, Luebeck, Germany; 3. Department of Urology, University Hospital of Regensburg, Regensburg, Germany; 4. Department of Urology, Pediatric Urology and Uro-Oncology, University Hospital of Essen, Essen, Germany; 5. Department of Urology and Pediatric Urology, University Hospital of Wuerzburg, Wuerzburg, Germany; 6. Department of Urology, University Hospital of Freiburg, Freiburg im Breisgau, Germany
181
days
A prospective comparative study of mini-PCNL using Trilogy™ or thulium fibre laser with suction
AuthorsAbhijit Patil; Rohan Sharma; Darshit Shah; Ankit Gupta; Abhishek Singh; Arvind Ganpule; Ravindra Sabnis; Mahesh Desai
Affiliations1. Department of Urology, Muljibhai Patel Urological Hospital, Nadiad, India
54
days
External validation of the Palacios’ equation: a simple and accurate tool to estimate the new baseline renal function after renal cancer surgery
AuthorsAlessandro Tafuri; Marco Sandri; Alberto Martini; Umberto Capitanio; Guglielmo Mantica; Carlo Terrone; Maria Furlan; Claudio Simeone; Daniele Amparore; Francesco Porpiglia; Andrea Minervini; Andrea Mari; Maria Angela Cerruto; Alessandro Antonelli
Affiliations1. Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy; 2. Department of Urology, “Vito Fazzi” Hospital, Lecce, Italy; 3. Department of Neuroscience, Imaging and Clinical Sciences, “G. D’Annunzio” University, Chieti, Italy; 4. Big & Open Data Innovation Laboratory (BODaI-Lab), University of Brescia, Brescia, Italy; 5. Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy; 6. Unit of Urology, Division of Experimental Oncology, URI - Urological Research Institute, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy; 7. Department of Urology, Policlinico San Martino Hospital, University of Genoa, Genova, Italy; 8. Department of Urology, Spedali Civili of Brescia, Brescia, Italy; 9. Division of Urology, Department of Oncology, School of Medicine, University of Turin, San Luigi Hospital, Orbassano (Turin), Italy; 10. Department of Urology, University of Florence, Careggi Hospital, San Luca Nuovo, Florence, Italy
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days